ARTICLE | Company News
BioXell SpA, DanioLabs, Proskelia SA deal
March 22, 2004 8:00 AM UTC
DanioLabs will use its zebrafish models of osteoporosis and bone anabolism to evaluate vitamin D3 analogs that are being developed by Proskelia and BioXell to treat osteoporosis and secondary hyperpar...